US Patent Issued to FEDORA PHARMACEUTICALS on Jan. 20 for "Lactivicin compounds, their preparation and use as antibacterial agents" (Canadian Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,804, issued on Jan. 20, was assigned to FEDORA PHARMACEUTICALS INC. (Edmonton, Canada).

"Lactivicin compounds, their preparation and use as antibacterial agents" was invented by Renata Jankowska (Edmonton, Canada), Sameeh M. Salama (Edmonton, Canada) and Samarendra N. Maiti (Edmonton, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Lactivicin compounds of formula (I) and pharmaceutically acceptable salts of the compounds of formula (I) are provided, wherein the compounds comprise antibiotics suitable for use either alone or in combination with Beta-lactamase inhibitors and/or additional antibiotics (including Beta-lactam and non-Beta-lactam an...